Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (149K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Faucon, B
Right arrow Articles by Helene, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faucon, B
Right arrow Articles by Helene, C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 3181-3188

Footnote

Effect of third strand composition on triple helix formation: purine versus pyrimidine oligodeoxynucleotides

Effect of third strand composition on triple helix formation: purine versus pyrimidine oligodeoxynucleotides Bruno Faucon , Jean-Louis Mergny* and Claude Hélène

Laboratoire de Biophysique, Muséum National d'Histoire Naturelle, INSERM U201, CNRS UA481, 43 rue Cuvier 75005 Paris , France Received May 1, 1996; Revised and Accepted June 27, 1996

ABSTRACT

Exon 5 of the human aprt gene contains an oligopurine-oligopyrimidine stretch of 17 bp (5 ' -CCCTCTTCTCTCTCCT-3' ) within the coding region. (T,C)-, (G,T)- and (G,A)-containing oligonucleotides were compared for their ability to form stable triple helices with their DNA target. (G,T) oligodeoxynucleotides, whether parallel or antiparallel, were unable to bind to this sequence. This is in contrast to (G,A) (purine) and (T,C) (pyrimidine) oligonucleotides, which bind to the duplex at near neutral pH. Binding was highly sequence specific, as unrelated competitors were unable to interfere with target recognition. A major difference between the purine and pyrimidine oligodeoxynucleotides was observed in the kinetics of binding: the (G,A) oligonucleotide binds to its target much faster than the (T,C) oligomer. With the purine oligonucleotide, complete binding was achieved in a matter of minutes at micromolar concentrations, whereas several hours were required with the pyrimidine oligomer. Thus, the general observation that triplex formation is slow with pyrimidine oligodeoxynucleotides does not hold for (G,A) oligodeoxynucleotides. Purine and pyrimidine oligodeoxynucleotides covalently linked to a psoralen group were able to induce crosslinks on the double-stranded DNA target upon UV irradiation. This study provides a detailed comparison of the different types of DNA triplexes under the same experimental conditions.

INTRODUCTION

Triple helices were first observed in 1957 for polyribonucleotides ( 1 ). These polymer interactions suggested an approach to double-stranded DNA recognition called oligonucleotide-directed triple helix formation, whereby short oligonucleotides bind to the major groove of double helical DNA at specific sequences ( 2 , 3 ). Triple helix-forming oligonucleotides (TFOs) can compete with the binding of proteins ( 4 , 5 ) and affect transcription of a specific gene ( 6 - 11 ). TFOs have been used to target mutations to specific sites in selectable genes, in order to achieve permanent and inheritable changes in gene expression ( 12 , 13 ). One of the best characterized selectable genes is the aprt gene and well-defined selection procedures allow detection of mutagenic events. APRT-/- mutants are selectable in a medium containing a drug such as 2,6 diaminopurine, which is converted to a lethal metabolite by the APRT enzyme. The human aprt gene is 2.6 kb in length, contains 5 exons and is located on chromosome 16 ( 14 ). In order to develop an oligonucleotide-directed mutagenesis assay, we first investigated triplex formation on a double-stranded DNA fragment that mimicked part of the aprt exon 5 sequence.

At least two structural classes of triple helices exist that differ in sequence composition of the third strand and relative orientations of the phosphate-deoxyribose backbones. In the first class, the pyrimidine motif, the third strand binds parallel to the purine strand of the duplex, forming T.A*T and C.G*C+ triplets ( 2 , 3 , 15 , 16 ). The p K a of the imino group of cytosine, which must be protonated ( 17 ), is well below 7, making these triplexes pH dependent ( 18 , 19 ). Despite this handicap, DNA triple helices of the first motif have been reported at neutral pH, especially when cytosines on the third strand are replaced by 5-methylcytosines ( 20 , 21 ). In the second class, the purine motif, guanine-rich oligonucleotides bind to the purine strand of the duplex by reverse Hoogsteen hydrogen bonds. Purine-rich third strands can be designed to form either C.G*G and T.A*A triplets [(G,A) oligonucleotides] or C.G*G and T.A*T triplets [(G,T) oligonucleotides]. It should be noted that oligonucleotides containing G and T can also bind in a parallel orientation with respect to a polypurine target sequence, forming Hoogsteen C.G*G and T.A*T base triplets ( 22 , 23 ). Therefore, the orientation of (G,T)-containing oligonucleotides is sequence dependent. These triple helices often require a high divalent cation concentration. Additionally, the third strand, which is G rich, is prone to form intra- or intermolecular structures involving the formation of G tetrads. Such structures are stabilized by physiological concentrations of monovalent cations, such as potassium, making this self-association likely in vivo . As a result, the ability of the TFO to bind to its intended target is reduced ( 24 - 27 ). Purine oligonucleotides also have the potential to form another competing structure, a G.A parallel duplex ( 28 ). Thus, the optimal choice for triplex formation under physiological conditions is not straightforward.

This work was undertaken first to determine what target would be optimal on the aprt gene and then what type(s) of oligonucleotide [(T,C), (G,T) or (G,A)] would be the best choice to form a triplex with that particular target under near physiological conditions. Four parameters were taken into account for such a selection: the possibility of self-association, the affinity of binding, the kinetics of triplex association/dissociation and the specificity of formation. Previous reports have compared (G,A) and (G,T) oligonucleotides, but results have not demonstrated a clear or consistent trend. Articles dealing with a comparison of all three types of oligodeoxynucleotides are rare ( 29 ). In this report, we compare all three kinds of TFOs for their ability to bind an oligopurine-oligopyrimidine sequence of exon 5 in the human aprt gene.

MATERIALS AND METHODS

Oligodeoxynucleotides and DNA

Unmodified oligodeoxynucleotides were synthesized by Eurogentec (Belgium) on the 0.2 [mu]mol scale and treated as in Mergny et al. ( 30 ). All other oligodeoxynucleotides (with 5' or 3' acridine and/or psoralen substitutions) were synthesized by Appligene (Strasbourg, France) and used without further purification. Concentrations of all oligodeoxynucleotides were estimated by UV absorption at 30oC in a pH 8.0 buffer, using the sequence-dependent absorption coefficients given by Cantor and Warshaw ( 31 ). All concentrations were expressed in strand molarity. Genomic DNA was extracted from WR10 (a human lymphoblastoid cell line, a gift of Dr Tatsumi, Japan) using the QIAamp blood kit (Quiagen Inc.).

UV absorption spectrophotometry

All experiments were performed as in Noonber et al . ( 28 ). A hysteresis phenomenon was obtained. Such behavior, which is the result of slow association and dissociation kinetics, has already been described and analyzed for triple helix formation ( 32 ).

Non-denaturing gel electrophoresis

Oligodeoxynucleotides were labeled with T4 polynucleotide kinase (New England Biolabs) and [ 32 P]ATP (ICN). Radiolabeled double-stranded duplex (10 nM strand concentration) was incubated at 4oC in the presence or absence of a large excess of an unlabeled oligodeoxynucleotide third strand (1-20 [mu]M strand concentration) in 50 mM HEPES buffer, pH 7.2, with 10 mM MgCl 2 . After incubation for 0.3-48 h, samples were loaded on a non-denaturing 12% polyacrylamide gel. Migration lasted 2-4 h at 4oC. Gels were dried and analyzed on a phosphorimager instrument (Molecular Dynamics). For the specificity experiments, the double-stranded competitor (purified human genomic DNA or a synthetic 36 bp kallikrein duplex) was mixed with the specific labeled duplex prior to third strand addition.

DNase I footprint

DNase I footprinting of the triplex site upon addition of the third strand was performed on a 36 bp duplex. The 32 P-labeled purine strand (10 nM, 10 4 c.p.m.) was pre-incubated with its complementary strand at 37oC in a 120 [mu]l solution containing 20 mM Tris-HCl, pH 7.2, 5 mM MgCl 2 , 50 mM NaCl, 0.5 mM CaCl 2 . The TFOs were added (15 [mu]M) at 4oC. After a variable incubation time (from 0.75 to 48 h), DNase I was added (0.2 [mu]g/ml final concentration) and the digestion was stopped after 20 s by freezing at -80oC in the presence of 5 vol. ethanol. After ethanol precipitation, the digests were separated on a 15% denaturing polyacrylamide gel and analyzed.

Psoralen TFOs and UV crosslinking experiments

UV crosslinking experiments upon addition of the psoralen third strand were performed on a 36 bp aprt duplex or with the 36 bp kallikrein duplex. The 32 P-labeled purine or pyrimidine strand (both 10 nM) was pre-incubated with its complementary strand (20% molar excess) at 37oC in 50 mM HEPES buffer, pH 7.2, containing 130 mM KCl and 10 mM MgCl 2 . The TFOs were added (10 [mu]M). The mixture was heated to 50oC over 30 min and then incubated at 37oC for 90 min. UV irradiation was performed with an Orion lamp (200W Xe Hg lamp, after removal of wavelengths below 310 nm through a glass plate) for 10-300 s. After ethanol precipitation, the reaction products were separated on a 15% denaturing polyacrylamide gel.

RESULTS

Design of triplex-forming oligodeoxynucleotides

Triplex formation is mostly limited to oligopurine-oligopyrimidine stretches. Using GenBank, we have searched for sites within the human aprt gene that would bind to a (T,C), (G,T) or (G,A) oligonucleotide. Sequences were scanned for those containing a stretch of at least 12 contiguous purines or 12 contiguous pyrimidines. As psoralen-linked oligonucleotides mostly induce single base pair substitutions ( 12 , 13 , 33 ), we decided to exclude all intronic sequences, where a point mutation is not likely to induce a change of phenotype. Only coding sequences and exon-intron boundaries were analyzed. We have identified a site within exon 5 (positions 2702-2718, according to Broderick et al. ; 14 ) of the human aprt gene that is susceptible to forming a stable triplex with a TFO. The oligopurine-oligopyrimidine region is 17 bp long and contains nine C.G and eight A.T base pairs. The sequence of the human aprt coding region is 90% identical to the hamster sequence. However, a single base pair difference in the hamster homolog disrupts the oligopurine stretch in exon 5: the homologous hamster exon has only 14 purines in a row, which could explain why this site was not favorable for the hamster homolog ( 34 ).

Different types of oligodeoxynucleotides could form a triplex with this duplex. We analyzed the interactions of several single-stranded oligodeoxynucleotides: 17TC, 5'-TCCTCTCTCTTCTTCCC; 17GA, 5'-GGGAAGAAGAGAGAGGA; 17GTa, 5'-GGGTTGTTGTGTGTGGT; 17GTp, 5'-TGGTGTGTGTTGTTGGG (see Fig. 1 ). The orientation of (T,C) and (G,A) TFOs in triple helical complexes is well established. Therefore, the (T,C) oligodeoxynucleotide was synthesized in a parallel orientation to the purine strand, whereas the (G,A) oligonucleotide was synthesized in the reverse orientation, i.e. antiparallel to the purine strand. This is in contrast to (G,T) oligonucleotides, which may bind in both orientations depending on the sequence context ( 22 ). Only the (G,T) oligonucleotide was synthesized in both orientations, both parallel (17GTp, 5'-d-TGGTGTGTGTTGTTGGG-3') and antiparallel (17GTa, 5'-d-GGGTTGTTGTGTGTGGT) to the oligopurine strand.


Figure 1 . ( A ) Organization of the aprt gene, the sequence of the oligopurine region in exon 5 and the sequences of the TFOs used in this study. A nearby TpA site (putative target for psoralen cross-linking experiments) is shown in bold. m above a C stands for 5-methylcytosine. ( B ) Sequence of the control duplex used in the competition studies. This duplex is homologous to the aprt sequence, with two base pair substitutions in the triplex area, shown in bold.

Self-association of the TFOs

Many cytosine-rich pyrimidine oligodeoxynucleotides are potentially able to form an intramolecular i-motif ( 30 ). No structure was observed for the 17TC and 17TC m oligonucleotides, probably because most cytosines are dispersed in the primary sequence.

We did not observe any self-associated structure for the (G,T) oligonucleotides (17GTa and 17GTp). Figure 2 (open triangles) illustrates the monotonous behavior of the absorbance of the 17GTa oligodeoxynucleotide as a function of temperature. No anomaly of migration was observed on a non-denaturing gel (not shown). The absence of self-association for such a (G,T) oligonucleotide is probably the result of dispersion of guanines in the TFO: the largest block of continuous guanines is only three bases long and most of the sequence is composed of (G,T) dinucleotides. This sequence is not favorable to guanine quadruplex formation.


Figure 2 . Evidence for self-association of the TFOs. UV melting profile of the TFOs: diamonds, 17GA oligonucleotide, 2 [mu]M strand concentration, absorbance values on right scale; open circles, 17GA oligonucleotide, 5 [mu]M strand concentration, absorbance on left scale; open triangles, 17GTa oligonucleotide, 5 [mu]M strand concentration, absorbance on left scale. 10 mM MgCl 2 , 50 mM HEPES buffer, pH 7.2.

The situation was very different for the 17GA oligonucleotide. In this case, self-association was observed as a hypochromism at 260 nm (Fig. 2 ) and a concentration-dependent migration profile on the gel (not shown). The melting profile is also concentration dependent (compare the profiles at 2 and 5 [mu]M in Fig. 2 ) and shifted to higher temperatures at high concentrations, in agreement with a bi-molecular process. The presence of bands of intermediate migration for variable strand concentrations has already been reported for (G,A) duplexes ( 28 ). This self-association of the (G,A) oligonucleotide might partially or totally inhibit triple helix formation, depending on the relative stabilities of these structures.

Stability and kinetics of triplex formation

The binding of a pyrimidine third strand into the major groove of a duplex is usually accompanied by hypochromism at 260 nm. Thus, the process of triplex formation can be monitored by measuring the change in absorbance as a function of temperature. A melting temperature of 15oC was obtained for the 17TC oligonucleotide at 1 [mu]M strand concentration in a pH 6.8 buffer containing 10 mM sodium cacodylate, 10 mM MgCl 2 and 140 mM KCl. Replacement of cytosines by 5-methylcytosines stabilized the triplex by >10oC (17TC m , T m = 28oC under the same experimental conditions). Raising the pH by only 0.4 units (i.e. to 7.2) led to disappearance of the transition corresponding to the triplexes for all pyrimidine TFOs (17TC, 18TC, 17TC m and 18TC m ), showing that these triple helices are strongly pH dependent.

Psoralen-conjugated oligonucleotides are able to crosslink a double-stranded DNA target at a 5'-TpA site ( 35 ) and such a site is present close, but not adjacent, to the oligopurine stretch. Therefore, we measured the stability of triple helices containing an extra non-canonical base triplet (on the left side of Fig. 1 A). This extra base on the third strand would be of interest to reach a nearby TpA site. For the pyrimidine oligonucleotide, we incorporated a G at the 3'-end of the TFO. This guanine should form an A.T*G base triplet, which is of reasonable stability ( 36 ). Binding of the 18mer was compared with binding of the corresponding 17mers. A small increase in the melting temperature was observed, suggesting that the A.T*G triplet is formed ( T m = 18oC, [Delta] T m = +3oC). Similar results were obtained when comparing 17TC m and 18TC m (data not shown).

No melting transition was observed with the 17GTa, 17GTp, 17GA and 18GA oligodeoxynucleotides. Triple helix formation without hypochromicity has already been described in a few cases ( 37 ). The absence of a spectral transition does not necessarily exclude triplex formation. Triplex formation must be evidenced using other techniques, such as gel retardation assays and/or footprinting experiments.


Figure 3 . Evidence for triplex formation with the oligodeoxynucleotides: DNase I footprinting of the duplex in the absence (lane 1) or presence of various third strands, 15 [mu]M strand concentration. Lane 2, 17TC; lane 3, 17TC m ; lane 4, 18TC; lane 5, 18TC m ; lane 6, 17GA; lane 7, 18GA; lane 8, 17GTa; lane 9, 17GTp. The TFOs were added at 4oC 45 min before DNase I cleavage (reaction time 20 s). For experimental conditions see Materials and Methods.


Figure 4 . Kinetics of triple helix formation for the (T,C) and (G,A) oligonucleotides. ( A ) Gel retardation profiles: left, 17TC m , 3 [mu]M strand concentration; right, 17TC m 15 [mu]M strand concentration. Lane 1, duplex alone. Lanes 2-7, increasing incubation times with the 17TC m oligonucleotide, 3 [mu]M strand concentration; lane 2, 20 min; lane 3, 2 h; lane 4, 4 h; lane 5, 6 h; lane 6, 20 h; lane 7, 48 h. Lanes 8-13, increasing incubation times of the 17TC m oligonucleotide, 15 [mu]M strand concentration; lane 8, 20 min; lane 9, 2 h; lane 10, 4 h; lane 11, 6 h; lane 12, 20 h; lane 13, 48 h. T, triplex; D, duplex. 15% non-denaturating polyacrylamide gel at 10oC. ( B ) Gel retardation profiles: left, 17GA, 3 [mu]M strand concentration; right, 17GA 15 [mu]M strand concentration. Lane 1, duplex alone. Lanes 2-7, increasing incubation times with the 17GA oligonucleotide at 3 [mu]M strand concentration; lane 2, 20 min, lane 3, 2 h; lane 4, 4 h; lane 5, 6 h; lane 6, 20 h; lane 7, 48 h. Lanes 8-13, increasing incubation times of the 17GA oligonucleotide at 15 [mu]M strand concentration; lane 8, 20 min; lane 9, 2 h; lane 10, 4 h; lane 11, 6 h; lane 12, 20 h; lane 13, 48 h. T, triplex; D, duplex. ( C ) Quantitative analysis of the gels shown in (A) and (B) at 3 [mu]M strand concentration. The amount of triplex formed is plotted against the incubation time (delay between TFO addition and loading on the gel). Open circles, 17TC m ; filled circles, 17GA.

For the reasons discussed above (possibility of reaching a 5'-TpA-3' step with a psoralen-substituted oligodeoxynucleotide), an adenine was added at the 5'-end of the purine TFO. No natural base is entirely satisfactory opposite a T.A base pair in the purine motif. To provide evidence for triplex formation with a purine oligodeoxynucleotide, footprinting experiments were performed with a labeled duplex. As shown in Figure 3 , DNase I is able to cleave a short double-stranded fragment containing the TFO binding site (lane 1), even in the presence of a large excess of an unrelated oligonucleotide. In the incubation buffer, no footprint was obtained at 4oC with the pyrimidine oligodeoxynucleotides (17TC and 18TC, lanes 3 and 4). With a 5-methylcytosine-substituted TFO, a weak protection was visible at the center of the putative triplex (18TC m , lane 5). This suggests that, in the incubation buffer used for DNase I cleavage, the triplex can be displaced by the enzyme. In contrast, the enzymatic cleavage profile was strongly altered with the 17GA (lane 6) and 18GA (lane 7) oligodeoxynucleotides, showing a typical protection from cleavage in most of the triplex region and strong hypersensitive sites at one of the duplex-triplex junctions (on the 3'-side of the target oligopurine region). This enhanced cleavage (which is not observed with a pyrimidine third strand) is probably the result of a distortion at the triplex-duplex junction. No protection at all was observed with the (G,T) oligonucleotides, whether parallel or antiparallel (lanes 8 and 9). The footprint presented in Figure 3 was obtained after a 45 min incubation time. Since this duration might not be sufficient to allow for triplex formation in all cases, we performed an identical experiment with an incubation time of 48 h. No differences in the cleavage patterns were obtained compared with Figure 3 (data not shown).

Gel retardation assays and kinetics of binding

UV melting experiments suggested that pyrimidine oligonucleotides were able to form a triplex, whereas footprinting experiments suggested that (G,A) oligonucleotides formed a stable triple helix. A third technique was thus initiated to confirm triplex formation. A retarded band is expected on a polyacrylamide non-denaturing gel upon third strand binding. No retarded band was ever observed with (G,T) third strands (17GTa or 17GTp), even at very high strand concentration (30 [mu]M; data not shown). Thus, no triplex was found for this family of TFO by three different techniques.

In contrast, a retarded band was observed with the (T,C) and (G,A) oligonucleotides (Fig. 4 A and B respectively), in agreement with triplex formation. The amount of triplex formed was measured after various incubation times. The thermodynamic properties of triple helices involving a pyrimidine oligonucleotide have been thoroughly investigated. Fewer experiments have been performed to determine kinetic parameters of triplex formation. As shown in Figure 4 C, incubation times of several hours at 4oC were required to obtain complete triplex formation with the 17TC oligonucleotide (3 [mu]M strand concentration) in a 50 mM HEPES, pH 7.2, 10 mM MgCl 2 buffer. As expected, an increase in the third strand concentration led to faster binding. In contrast, (G,A) oligonucleotide binding was maximum with a very short incubation time (20 min). Even if heat denatured for 20 min just prior to loading, a sample containing the (G,A) TFO and the duplex showed partial but significant triplex re-formation (19%). The minor but significant and reproducible decrease in binding over time (Fig. 4 C) for very long periods is probably the result of competing self-association(s) of the (G,A) third strand.

This result, as well as the footprint obtained after only 45 min, indicated that (G,A) oligonucleotides indeed formed a triplex and that the formation was fast compared with the (T,C) oligodeoxynucleotide. Twenty minutes were sufficient to obtain optimal binding at 3 [mu]M strand concentration of the (G,A) TFO, whereas 20 h were necessary for the (T,C) TFO at neutral pH. This indicates that (G,A) triplexes form at a much faster rate than (T,C) triplexes.

Specificity of triplex formation

Sequence-specific binding of purine as well as pyrimidine oligodeoxynucleotides has already been established. We wanted to determine whether the specificity of our TFOs would be sufficient to recognize a complementary target in the presence of a very large excess of competitor. We assayed two types of competitors: (i) a target duplex with two point substitutions; (ii) total human genomic DNA. The sequence of the mutated duplex is shown in Figure 1 B. It partially corresponds to the sequence of the polypurine-polypyrimidine stretch found in the sequence of the human kallikrein gene. The labeled aprt target duplex (10 nM strand concentration) was first mixed with increasing amounts of an unlabeled competitor duplex (the kallikrein duplex shown in Fig. 1 B). The 18TC m or 18GA TFOs were then added. The mixture was incubated for 15 h at 4oC then loaded on a 15% non-denaturating polyacrylamide gel at 10oC. The retarded band corresponding to the triplex was completely unaffected by the presence of the non-specific competitor (data not shown). It is interesting to note that the 18mers still bind to their targets with high specificity. Thus, the extra base on the TFO does not have any deleterious effect on the specificity of binding. Even a large excess (1000 times or more) of a closely related duplex was unable to displace a significant proportion of the third strand.

Acridine-substituted TFO

The linkage of DNA ligands, especially intercalators, has been previously described to enhance the affinity of TFOs. Covalent linkage of an acridine derivative at one end of the TFO was shown to increase the binding affinity ( 38 , 39 ). The presence of an acridine moeity at the 5'-end of a (T,C) TFO strongly increased the stability of the triplex: at pH 7.2 or above, no significant triplex formation was evident with the 18TC m TFO. A small hyperchromism at 260 nm could only be obtained with a long incubation time at 0oC before heating. In contrast, Acr-18TC m melts in a non-reversible fashion, with a T m of 25oC at pH 7.2 measured on the dissociation curve. Concerning the (G,A) TFOs, gel retardation experiments were performed at different strand concentrations in 50 mM HEPES, pH 7.2, containing 10 mM MgCl 2 . Apparent K d values, derived from the third strand concentration necessary to obtain 50% triplex formation at 4oC on a non-denaturing gel, were determined to be 0.3 [mu]M for the 18GA oligonucleotide and 0.03 [mu]M for the 18GA-Acr oligonucleotide (data not shown). Thus, the presence of an acridine group at the 3'-end of the purine TFO increases its affinity by a factor of 10.

Psoralen TFOs: crosslinking the DNA target

Doubly substituted TFOs, bearing an acridine group at one end and a psoralen group at the other end, were tested for their abilities to induce crosslinks at a nearby, but not adjacent, site (Fig. 1 A). The psoralen group was linked to the 5'-end of the (G,A) oligodeoxynucleotide and the 3'-end of the (T,C) oligodeoxynucleotide. Both oligonucleotides included an extra base towards the 3'-side of the polypurine target sequence, to allow psoralen intercalation at the TpA site. Comparison of the UV melting profiles of the Acr-18TC m and Acr-18TC m -Pso TFOs demonstrated that no further gain in stability was obtained with the doubly substituted pyrimidine TFO as compared with the acridine conjugate. In a similar fashion, the apparent K d values for the Pso-18GA-Acr ( K d = 20 nM) and 18GA-Acr ( K d = 30 nM) TFOs were almost identical, suggesting that the psoralen group did not play an important role in stability of the purine and pyrimidine triple helices.

The ability of the psoralen-substituted TFOs to induce crosslinking of their double-stranded DNA target upon UVA irradiation was tested by denaturing gel electrophoresis. One of the strands of the 36 bp aprt duplex was radioactively labeled and the duplex was formed upon addition of the unlabeled complementary strand. The psoralen TFO was then added and the mixture was incubated for a variable time (between 2 and 45 min), then UV irradiated. Figure 5 shows that both (G,A) and (T,C) TFOs could induce a significant number of crosslinks of the target after 90 min incubation at 37oC in a pH 7.2 buffer. The presence of an acridine moeity at the other end of the TFO was not necessary to observe crosslinks. An increase in the fraction of slowly migrating species was nevertheless obtained with Acr-18TC m -Pso TFO compared with 18TC m -Pso, suggesting that the acridine group stabilized the interaction between the pyrimidine TFO and its target sequence, which in turns facilitates positioning of the psoralen group at the TpA site. No such increase in crosslinking efficiency was observed for the Pso-18GA-Acr oligonucleotide, when compared with the Pso-18GA TFO: under these conditions, the Pso-GA TFO, without any acridine, induces a large fraction of slowly migrating species. No crosslinks were obtained with a mutated target duplex (Fig. 5 , right), demonstrating that psoralen crosslinks were abolished by the presence of only two mismatches on the triplex sequence. Thus, even doubly substituted TFOs (bearing one acridine and one psoralen group) are able to discriminate between their specific target and a related sequence.


Figure 5 . Specificity of the UV crosslinking reaction. Denaturing urea-PAGE of the covalent products obtained upon UV irradiation. Incubation in the presence of 10 [mu]M TFO (purine or pyrimidine) was performed at 37oC in 10 mM MgCl 2 , 50 mM HEPES buffer, pH 7.2. Irradiation was carried out at 37oC for 120 s. Lanes 1-4, aprt 36 bp duplex (10 nM strand concentration) is labeled. Lanes 5-8, the same experiment with a labeled kallikrein control duplex (10 nM strand concentration, sequence shown in Fig. 1). Lanes 1 and 5, 18TC m -Pso; lanes 2 and 6, Acr-18TC m -Pso; lanes 3 and 7, Pso-18GA; lanes 4 and 8, Pso-18GA-Acr.

As shown in Figure 6 , 2 min irradiation were sufficient to induce a large fraction of crosslinks on the DNA target. Up to 65% of the 36 bp DNA fragment was converted into a slowly migrating species with the Pso-18GA-Acr TFO (Fig. 6 A). Slightly less crosslinked product was obtained with the Acr-18TC-Pso third strand under the same experimental conditions (Fig. 6 B). In both cases, the monoadduct formed on the purine-rich strand appeared at short irradiation times and then slowly decreased. No crosslinks were obtained with the 18GA or 18GA-Acr oligodeoxynucleotides, showing that the presence of a psoralen group was a necessary condition to obtain these crosslinks. Finally, an unrelated psoralen-substituted TFO, 16 bases long, was unable to induce crosslinks in the aprt duplex, in agreement with sequence-specific binding of the third strand.


Figure 6 . Quantitation of the UV crosslinking experiments, after denaturing urea-PAGE analysis of the covalent products. The 36 bp duplex (10 nM strand concentration) was labeled on the purine strand with T4 polynucleotide kinase. Incubation was performed at 37oC in 10 mM MgCl 2 , 50 mM HEPES buffer, pH 7.2, and the mixture was then irradiated with a UV lamp for a variable amount of time (shown on the x -axis in seconds). ( A ) Pso-18GA-Acr TFO (10 [mu]M, strand concentration); ( B ) Acr-18TC m -Pso TFO (10 [mu]M, strand concentration). Squares, crosslinks; circles, monoadducts. See Figure 5 for an example of covalent products after UV irradiation. No covalent products were observed in the absence of UV irradiation.

DISCUSSION

Pyrimidine versus purine TFOs

We have tested three different types of oligonucleotides for their ability to bind to a 17 bp oligopurine-oligopyrimidine sequence present in exon 5 of the human aprt gene. (G,T) oligodeoxynucleotides, whether parallel or antiparallel, were unable to bind to the target sequence. This result is apparently surprising, as many studies have shown that (G,T) oligonucleotides could bind to double-stranded DNA. This rather weak binding is certainly the result of the primary sequence of the aprt oligopurine stretch: the corresponding third strand contains a large number of TpG and GpT steps. As the C.G*G and T.A*T base triplets are not isomorphous, every change of base on the TFO leads to a distortion of the third strand and thus to an energetic penalty. A comparison with the literature shows that (G,T) oligonucleotides which are able to form a triple helix are usually G rich rather than T rich, leading to the formation of a majority of C.G*G triplets, and (more importantly) these guanines are clustered, thus reducing the number of unfavorable GpT or TpG steps in the third strand. Long T stretches favor a parallel orientation of the (G,T) oligonucleotides, whereas long G stretches favor an antiparallel orientation ( 40 ). Thus, (G,T) oligonucleotides do not constitute a universal solution to triplex formation on any oligopurine-oligopyrimidine sequence.

(G,A) oligonucleotides (i.e. purine oligonucleotides) showed high affinity and specificity for the aprt sequence. Their main advantage over pyrimidine TFOs did not only rely on their pH-independent binding, but also on their kinetics of binding. Complete binding required several hours with an unmodified pyrimidine oligonucleotide (30 [mu]M strand concentration) at neutral pH. Under the same experimental conditions, the (G,A) oligonucleotide was fully bound to its target in a matter of minutes. No triplex formation at all was obtained with the (T,C) third strand under the same conditions (data not shown).

Having in mind the formation of triple helices in vivo , we tried in these in vitro experiments to maintain several important parameters close to physiological conditions: the pH was kept at ~7 in all experiments. The exact pH value in vivo will play a decisive role in the formation of a pyrimidine triplex, as a pH increase of 0.4 units was enough to destabilize the pyrimidine triplexes in vitro . The length, sequence and mismatch content of the triplex was of course defined by the sequence context of the aprt gene. As a consequence, the triplexes presented in this study were not very stable at 37oC. Relatively few studies have been performed to compare purine and pyrimidine TFOs on the same target ( 29 , 41 ). The choice of an oligodeoxynucleotide for triplex formation must take into account not only its ability to form a triplex, but also its ability to form an undesired, competing structure, such as G-quartets, (G,A) parallel duplexes or i-DNA. Self-association of the third strand does not necessarily prevent triplex formation. In our study, the (G,A) TFO did form a stable homoduplex, but was still able to recognize the duplex target. (G,A) duplex formation does interfere somehow with triplex formation and might explain why complete saturation of the duplex was not observed at high concentrations of the third strand. Such a competing structure may even lead to a situation where the triple helix is more readily formed at 37 than 4oC ( 28 ). (G,T) oligonucleotides were excluded, as none of them had a measurable affinity for the aprt sequence in vitro . It is thus interesting to note that the only oligonucleotide that self-associated in vitro [the (G,A) TFO] is the one with the greater affinity for the duplex. (T,C) oligonucleotides can form triple helices at neutral pH, but with a limited stability. The presence of an acridine group at one end of the pyrimidine third strand does improve the stability of the triplex, but the melting temperature of this TFO is still below 37oC at pH 7.2, making triplex formation with this type of TFO uncertain in vivo and stimulating the search for chemical modifications of the third strands (2'-O-methyl, phosphoramidates, etc.) that might improve the stability of these triplexes.

Covalent modification of the DNA target

The mutagenic potential of unmodified TFOs is significant, although they do not induce any direct covalent damage in their double-stranded targets ( 42 ). They probably induce mutations through a transcription-coupled repair mechanism. The mutagenic potential of unmodified (G,A) TFOs was nevertheless limited compared with psoralen-substituted (G,A) TFOs, which induce 10 times more mutations in the supF gene ( 33 ). A psoralen moiety can easily be attached to one end of the TFO and can be activated by UV, in order to form adducts with its DNA target ( 35 ). The most reactive base sequence for psoralen photoaddition is at the 5'-TpA-3' site. A TpA site is present in exon 5 of the human aprt gene, close to the triplex site.

To reach this putative psoralen intercalation site, we investigated TFOs having an extra base towards the 3'-end of the purine strand of the triplex (Fig. 1 A). We showed that the third strand can be extended without any energetic penalty (the extra mismatched triplet even provides extra stability to the triplex). Extension of a triplex region can thus be locally achieved as long as a canonical triplex is present, to `nucleate' the formation of the longer triple helix ( 43 ). We have shown that in vitro a pyrimidine oligodeoxynucleotide linked at its 3'-end to a psoralen group is able to induce a double-stranded crosslink on the DNA target at the TpA site. Similar results were obtained with a purine (G,A) TFO linked at its 5'-end to psoralen. The crosslinking experiments confirmed that (G,A) and (T,C) TFOs bind to their double-stranded DNA targets and are able to induce covalent modifications on a neighboring but not adjacent TpA site. The psoralen group, which provides a high chemical photoreactivity, does not increase the binding affinity of the third strand in this system, probably because the TpA site is not directly adjacent to the triplex site. This experiment shows that the presence of a TpA site at the triplex-duplex junction is not an absolute requisite for psoralen crosslinking; a neighboring TpA site which is close to the duplex-triplex junction can be reached by the psoralen group, provided that one (or more) extra base(s) is present at the corresponding end of the TFO. Such an additional nucleotide, which cannot lead to the formation of canonical base triplets, may still play a limited role in triplex stability and does not prevent the TFO from being highly sequence specific.

In summary, we have shown that, in the sequence context of exon 5 of the aprt gene, triple helix formation is possible with (T,C) and (G,A) TFOs. A major difference between these two classes of triple helices rests upon their kinetics of binding to their double-stranded target. Both psoralen-linked purine and pyrimidine TFOs were able to induce crosslinks in the aprt sequence at a TpA site not adjacent to the duplex-triplex junction. Experiments are now being conducted in cell cultures, using human cell lines heterozygous for the aprt gene, doubly substituted TFOs (having one end linked to acridine, the other to psoralen) and UVA irradiation. On the basis of the present in vitro experiments, (G,A) and (T,C) oligonucleotides, but not (G,T) TFOs, are currently under investigation to determine their abilities to induce site-directed mutagenesis in an endogenous gene.

REFERENCES

1 Felsenfeld,G., Davies,D.R. and Rich,A. (1957) J. Am. Chem. Soc., 79, 2023.

2 Le Doan,T., Perrouault,L., Praseuth,D., Habhoub,N., Decout,J.-L., Thuong,N.T., Lhomme,J. and Hélène,C. (1987) Nucleic Acids Res., 15, 7749-7760. MEDLINE Abstract

3 Moser, H.E. and Dervan, P.B. (1987) Science, 238, 645-650. MEDLINE Abstract

4 François, J.C., Saison-Behmoaras, T., Thuong, N.T. and Hélène, C. (1989) Biochemistry, 28, 9617-9619. MEDLINE Abstract

5 Maher,L.J., Wold,B. and Dervan,P.B. (1989) Science, 245, 725-730. MEDLINE Abstract

6 Cooney,M., Czernuszewicz,G., Postel,E.H., Flint,S.J. and Hogan,M.E. (1988) Science, 241, 456-459. MEDLINE Abstract

7 Young,S.L., Krawczyk,S.H., Matteucci,M.D. and Toole,J.J. (1991) Proc. Natl. Acad. Sci. USA, 88, 10023-10026. MEDLINE Abstract

8 Maher,L.J., Dervan,P.B. and Wold,B. (1992) Biochemistry, 31, 70-81.

9 Duval-Valentin,G., Thuong,N.T. and Hélène,C. (1992) Proc. Natl. Acad. Sci. USA, 89, 504-508.

10 Grigoriev,M. et al. (1992) J. Biol. Chem., 267, 3389-3395. MEDLINE Abstract

11 Ing,N.H. et al. (1993) Nucleic Acids Res., 21, 2789-2796. MEDLINE Abstract

12 Havre,P.A., Gunther,E.J., Gasparro,F.P. and Glazer,P.M. (1993) Proc. Natl. Acad. Sci. USA, 90, 7879-7883. MEDLINE Abstract

13 Sandor,Z. and Bredberg,A. (1994) Nucleic Acids Res., 22, 2051-2056. MEDLINE Abstract

14 Broderick,T.P., Schaff,D.A., Bertino,A.M., Dush,M.K., Tishfield,J.A. and Stambrook,P.J. (1987) Proc. Natl. Acad. Sci. USA, 84, 3349-3353. MEDLINE Abstract

15 de los Santos,C., Rosen,M. and Patel,D. (1989) Biochemistry, 28, 7282-7289. MEDLINE Abstract

16 Rajagopal,P. and Feigon,J. (1989) Nature, 339, 637-640. MEDLINE Abstract

17 Lavelle,L. and Fresco,J.R. (1995) Nucleic Acids Res., 23, 2692-2705. MEDLINE Abstract

18 Manzini,G., Xodo,L.E., Gasparotto,D., Quadrifoglio,F., van der Marel,G.A. and van Boom,J.H. (1990) J. Mol. Biol., 213, 833-843. MEDLINE Abstract

19 Hüsler,P.L. and Klump,H.H. (1995) Arch. Biochem. Biophys., 317, 46-56. MEDLINE Abstract

20 Lee,J.S., Woodsworth,M.L., Latimer,L.J.P. and Morgan,A.R. (1984) Nucleic Acids Res., 12, 6603-6614. MEDLINE Abstract

21 Xodo,L.E., Manzini,G., Quadrifoglio,F., van der Marel,G.A. and van Boom,J.H. (1991) Nucleic Acids Res., 19, 5625-5631. MEDLINE Abstract

22 Sun,J.S., De Bizemont,T., Duval-Valentin,G., Montenay-Garestier,T. and Hélène,C. (1991) CR. Acad. Sci. Paris Sér III, 313, 585-590.

23 Giovannangéli,C., Montenay-Garestier,T., Thuong,N.T. and Hélène,C. (1992) Proc. Natl. Acad. Sci. USA, 89, 8631-8635. MEDLINE Abstract

24 Cheng,A.-J. and Van Dyke,M.W. (1993) Nucleic Acids Res., 21, 5630-5635. MEDLINE Abstract

25 Milligan,J.F., Krawczyk,S.H., Wadwani,S. and Matteucci,M.D. (1993) Nucleic Acids Res., 21, 327-333. MEDLINE Abstract

26 Olivas,W.M. and Maher,L.J. (1995) Biochemistry, 34, 278-284. MEDLINE Abstract

27 Olivas,W.M. and Maher,L.J. (1995) Nucleic Acids Res., 23, 1936-1941. MEDLINE Abstract

28 Noonberg,S.B., François,J.C., Garestier,T. and Hélène,C. (1995) Nucleic Acids Res., 25, 1956-1963.

29 Roy,C. (1993) Nucleic Acids Res., 21, 2845-2852. MEDLINE Abstract

30 Mergny,J.L., Lacroix,L., Han,X., Leroy,J.L. and Hélène,C. (1995) J. Am. Chem. Soc., 117, 8887-8898.

31 Cantor,C.R. and Warshaw,M.M. (1970) Biopolymers, 9, 1059-1077. MEDLINE Abstract

32 Rougée,M., Faucon,B., Mergny,J.L., Barcelo,F., Giovannangéli,C., Garestier,T. and Hélène,C. (1992) Biochemistry, 31, 9269-9278. MEDLINE Abstract

33 Wang,G., Levy,D.D., Seidman,M.M. and Glazer,P.M. (1995) Mol. Cell. Biol., 15, 1759-1768. MEDLINE Abstract

34 Vasquez,K.M., Wensel,T.G., Hogan,M.E. and Wilson,J.H. (1995) Biochemistry, 34, 7243-7251. MEDLINE Abstract

35 Takasugi,M., Guendouz,A., Chassignol,M., Decout,J.L., Lhomme,J., Thuong,N.T. and Hélène,C. (1991) Proc. Natl. Acad. Sci. USA, 88, 5602-5606. MEDLINE Abstract

36 Radhakrishnan,I. and Patel,D.J. (1992) J. Am. Chem. Soc., 114, 6913-6915.

37 Jetter,M.C. and Hobbs,F.W. (1993) Biochemistry, 32, 3249-3254. MEDLINE Abstract

38 Sun,J.S. et al. (1991) Proc. Natl. Acad. Sci. USA, 88, 6023-6027. MEDLINE Abstract

39 Stonehouse,T.J. and Fox,K.R. (1994) Biochim. Biophys. Acta Gene Struct. Expression, 1218, 322-330.

40 de Bizemont,T., Duval-Valentin,G., Sun,J.S., Bisagni,E., Garestier,T. and Hélène,C. (1996) Nucleic Acids Res., 24, 1136-1143. MEDLINE Abstract

41 Cheng,Y.K. and Pettitt,B.M. (1992) J. Am. Chem. Soc., 114, 4465-4474.

42 Wang,G., Seidman,M.M. and Glazer,P.M. (1996) Science 271, 802-805. MEDLINE Abstract

43 Chandler,S.P. and Fox,K.R. (1995) FEBS Lett., 360, 21-25. MEDLINE Abstract


Return

* To whom correspondence should be addressed
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. C. de Almagro, S. Coma, V. Noe, and C. J. Ciudad
Polypurine Hairpins Directed against the Template Strand of DNA Knock Down the Expression of Mammalian Genes
J. Biol. Chem., April 24, 2009; 284(17): 11579 - 11589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. C. Raghavan, P. Chastain, J. S. Lee, B. G. Hegde, S. Houston, R. Langen, C.-L. Hsieh, I. S. Haworth, and M. R. Lieber
Evidence for a Triplex DNA Conformation at the bcl-2 Major Breakpoint Region of the t(14;18) Translocation
J. Biol. Chem., June 17, 2005; 280(24): 22749 - 22760.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
D. Murphy, R. Eritja, and G. Redmond
Monitoring denaturation behaviour and comparative stability of DNA triple helices using oligonucleotide-gold nanoparticle conjugates
Nucleic Acids Res., April 23, 2004; 32(7): e65 - e65.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. D. Keppler, S. Neidle, and K. R. Fox
Stabilisation of TG- and AG-containing antiparallel DNA triplexes by triplex-binding ligands
Nucleic Acids Res., May 1, 2001; 29(9): 1935 - 1942.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P. B. Arimondo, T. Garestier, C. Helene, and J.-S. Sun
Detection of competing DNA structures by thermal gradient gel electrophoresis: from self-association to triple helix formation by (G,A)-containing oligonucleotides
Nucleic Acids Res., February 15, 2001; 29(4): e15 - e15.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. M. Gewirtz, D. L. Sokol, and M. Z. Ratajczak
Nucleic Acid Therapeutics: State of the Art and Future Prospects
Blood, August 1, 1998; 92(3): 712 - 736.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (149K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Faucon, B
Right arrow Articles by Helene, C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faucon, B
Right arrow Articles by Helene, C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?